Bruns Ingmar

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 6%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Bruns Ingmar's trades of Zentalis Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
197.56
Quantity 93,168 +49.7%
Value US$832,366
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-10 2026-02-09
S Sale
50,139 -3.9%
405.55
US$3,357,912 		50,139 -3.9% 405.55 US$3,357,912
2026-02-10 2026-02-06
S Sale
45,395 -18.3%
467.33
US$2,122,217 		45,395 -18.3% 467.33 US$2,122,217
2025-02-12 2025-02-06
B Purchase
93,168 +49.7%
197.56
US$832,366 		93,168 +49.7% 197.56 US$832,366